According to the study published the journal Archives of Disease in Childhood, researchers say that more than 15 percent of children studied who were born via c-section were obese by age 3, while only 7.5 percent of the babies delivered vaginally were obese at that age.

The numbers held up, the researchers said, when they also factored in the mother's body mass index and the baby's weight at birth.

"Almost one in three children are delivered by C-section in the U.S., and if cesarean delivery is a risk factor for obesity, this would be an important reason to avoid them if they aren 't necessary," Dr. Susanna Huh, the survey's lead author, told ABC News.

Researchers aren't exactly sure what leads to this trend, but they theorize it could be due to healthy bacteria passed through during vaginal delivery or insulin resistance.

Linda Harmon, the executive director for Lamaze International, says women shouldn't automatically assume that c-sections are easier.

"I think some people do and don't realize the long term and short term potential risks there are for mom and baby," Harmon said.

However, some doctors have called the results of the study "inconceivable" and remind women that in many cases, a cesarian section delivery may be necessary for medical reasons.

"He said to me, 'You have lung cancer.' I said, 'What?! I've never even smoked a day in my life!'," Greta says.

But, on the cat-scan there was a half-inch tumor on her left lung.

Lung cancer kills more Americans than Colorectal cancer, breast cancer, prostate cancer and pancreatic cancer combined.  This year, an estimated 160,340 Americans will die from the disease, making lung cancer the leading cause of death in America after heart disease.

And the five year survival rate is about 15 percent, as the symptoms usually don't show up until it's too late. Some of those symptoms include:

--coughing
--shortness of breath
--wheezing
--hoarseness
--coughing up blood
--fatigue
--chest, shoulder, back or arm pain
--pneumonia

Laurie Fenton Ambrose, president of the Lung Cancer Alliance, says,
"We are seeing more, and particularly women, being diagnosed with lung cancer, who have never smoked."

The Lung Cancer Alliance says 80 percent of new lung cancer patients either quit smoking years ago or have ever smoked at all.

Greta wondered what caused her cancer. Her parents smoked, like so many in the 50s and 60s. So, was it second-hand smoke?

Or maybe genetics? Her sister died of the disease, but she had also been a smoker.

Other possible risk factors for lung cancer are: smoking (including cigarettes, cigars and pipes), radon and asbestos exposure, lung cancer in immediate family (regardless of whether they smoked), military/veterans exposed to Agent Orange and certain other chemicals, those with respiratory diseases; e.g., emphysema, COPD and tuberculosis and hormone replacement therapy.

"I wish I could tell you we had an answer. We don't, because this is a disease that has been so stigmatized...and so underfunded," Ambrose explains.

Last month, Greta underwent surgery at George Washington University Hospital. At stage 1, the cancer had not spread.

Surgeons removed Greta's lower left lobe as a precaution.

Greta says her lung capacity is almost back to normal.  And five weeks after surgery, she's back at work. and definitely one of the lucky ones.

"You probably have an 80 percent, if not a little bit higher, chance of being cured from this," thoracic surgeon Dr, Marc Margolis says to Greta.

"That's pretty good! Very good. I like those odds!," she responds.

Greta didn't have to undergo any chemo or radiation, but she must have frequent C-T scans for the next five years.

MORE INFORMATION

LUNG CANCER ALLIANCE (LCA)
www.lungcanceralliance.org
Phone: 202-463-2080
Lung Cancer Information Line: 1-800-298-2436 (9:00am to 5pm est)

WHERE TO GO FOR LUNG CANCER SCREENING
http://www.screenforlungcancer.org/where-do-i-go/

AMERICAN CANCER SOCIETY
www.cancer.org

NATIONAL LUNG CANCER PARTNERSHIP
www.NationalLungCancerPartnership.org

NATIONAL CANCER INSTITUTE
(U.S. Department of Health and Human Services/ National Institutes of Health)
http://www.cancer.gov
1-800-4-CANCER
(1-800-422-6237)

LOW-DOSE SPIRAL CT SCAN STUDY
http://www.cancer.gov/newscenter/pressreleases/2010/NLSTresultsRelease

Thereport found that 24 states received scores of five or lower on a set of steps states can take to prevent injuries.

The Metro region ranked above average with Maryland scoring an eight of out a possible 10. D.C. scored a seven and Virginia a six.

Two states, California and New York, received the highest score of nine, while two states scored the lowest, Montana and Ohio, with two, the study says.

The report ranks states by the number of deaths from injuries and grades the states on ways they make themselves safer.

Executive Director Jeff Levi appeared on ABC7’s Good Morning to give a breakdown on our region.

More information:http://healthyamericans.org/reports/injury12/

The woman called 911 because her husband was turning blue and having difficulty breathing.

It's 5 minutes and 43 seconds into the emergency 911 call, before the dispatcher finally wakes up.

The snoring dispatcher, whose name is not being released, was working a typical 24 hour shift - when the incident happened shortly after midnight on April 4th.

Chief Administrative Law Judge Michael Chappell sided with federal regulators and ordered POM to halt all claims of health benefits and performance for its beverage. Expert witnesses testified in court that scientific evidence does not support claims made in company advertising, which appeared in national newspapers, magazines and online.

The Federal Trade Commission filed a complaint against POM and its parent company, Los Angeles-based Roll International Corp., in September 2010. The company's health claims are a hallmark of its advertising and are seen as working to convince consumers that they are worth a premium price.

POM Wonderful is credited with having started the pomegranate craze that has spread to everything from smoothies to salad dressings.

Chappell did not completely agree with FTC's complaint, rejecting an argument that the company should have to provide evidence from rigorous medical trials- the same standard required of pharmaceutical companies. Instead, the judge said the company could provide "competent reliable scientific evidence."

Los Angeles-based POM Wonderful said in a statement, "We consider this not only to be a huge win for us, but for the natural food products industry."

The judge's ruling becomes final after 30 days, unless the company appeals. POM said it is "continuing to review the ruling," but did not indicate plans to appeal.

In addition to POM Wonderful juice, the company sells POMx pills and liquid extract.

As part of the so-called "Stroller Brigade," mothers like Hanna Pingree took their message to Capitol Hill to lobby for more scrutiny of chemicals in baby products.

The group rallied in support of Sen. Frank Lautenberg's (D-N.J.) Safe Chemicals Act, which would overhaul what many call antiquated laws governing toxic chemicals.

"The more I find out about chemicals in products that I buy for my child, the more angry I get," Pingree said.

Lautenberg said that the current regulations allow too many untested chemicals onto the market. A comprehensive chemical act hasn't been passed by Congress in more than 30 years. Supporters say that the time has come for stricter laws.

"Why should parents be left to wonder if the chemicals used in their bottles, pacifiers and cribs are safe?" Lautenberg said. "The status quo is dangerous and unacceptable.

Chesapeake, Va. resident Lisa Allen brought her two boys to D.C. and was stunned when she heard the nursing pillow she used contained potentially dangerous chemicals.

"I feel like I'm a pretty informed mom," Allen said. "I make informed decisions, but there's still not enough information out there."

The U.S. Preventive Services Task Force gave a nearly failing grade for "prostate-specific-antigen" or PSA testing. It got a “D.” The group says getting the test causes more harm than good.

Less than a year ago, Garry Westcott of Alexandria, Virginia, didn’t know how long he had left to live. A doctor discovered he had prostate cancer.

“I had no symptoms. I had no indications that I had cancer other than the PSA test,” said now-cancer survivor Westcott.

The 63 year-old got the routine blood test after a physical. When his PSA came back high, he had his prostate biopsied, then had the cancer cut out.
“Had I not had the PSA test, my story and the list of procedures could be a whole different ball game,” Westcott said.

For nearly two decades, the message has been the same: get a PSA test every year or two to detect prostate cancer early. Now, a federal advisory panel is recommending otherwise, saying the screening is unreliable—giving a false positive 80 percent of the time.

"Panic was the number one thing in my mind and the doctors said the only way to make sure you're done is to get it out,” said Paul Nelson, Erectile Dysfunction Foundation President.

Paul Nelson, 51, had his prostate removed right away after his PSA came back high. But, in cases like Paul’s, the side effects of surgery are sometimes worse than the disease.

"I actually think impotence and incontinence are some of the minor side effects. Some of them are actually going to have significant problems like pulmonary emboli, heart attacks," said Dr. Otis Brawley, the American Cancer Society Chief Medical Officer.

Westcott says you can debate the pros and cons indefinitely, but, what it boils down to is education.

“I think it needs to be explained to patients who get fearful right away that...doctors have to go through and explain...this does not necessarily mean you have cancer. It's an indicator that we're going by because frankly it's the best indicator we have now,” Westcott said.

The American Cancer Society says it's going to work hard to find a screening test that actually works—before making it widely available to the public again.

Of course, everyone has to discuss this with their doctor and make a personal choice.

Doctor Lynch with Georgetown Lombardi Comprehensive Cancer Center issued a statement saying "it's a disservice to men to deny them the opportunity for potential treatment and cure...when necessary... For a disease that affects one in six over the course of their lifetime."

Despite strenuous protests from urologists, the U.S. Preventive Services Task Force is sticking by a contentious proposal it made last fall. A final guideline published Monday says there's little if any evidence that PSA testing saves lives - while too many men suffer impotence, incontinence, heart attacks, occasionally even death from treatment of tiny tumors that never would have killed them.

The guideline isn't a mandate. The task force stresses that men who want a PSA test still can get one, but only after the doctor explains the uncertainties. That's in part because the panel found PSA testing hasn't been studied adequately in black men and those with prostate cancer in the family, who are at highest risk of the disease.

The Obama administration said Monday that Medicare will continue to pay for PSA screenings, a simple blood test. Other insurers tend to follow Medicare's lead.

"This is important information for the public and men to have, and they should talk with their doctors about the risks and benefits of prostate cancer screening and make the decision that's best for them," said Mark Weber, a spokesman for the Department of Health and Human Services.

The task force advice goes a step further than major health groups including the American Cancer Society, which has long urged that men decide the issue for themselves after being told of PSA's pros and cons. But it's not likely to end an annual ritual for many men 50 and older. After all, the same task force has long urged men over 75 to skip PSA screening, and research suggests almost half of them still get tested.

The controversy will end only with development of better tests - to finally tell which men's tumors really will threaten their lives, and who will die with prostate cancer rather than from it, said Dr. Virginia Moyer of the Baylor College of Medicine, who heads the task force.

"We have been told for decades to be terrified of cancer and that the only hope is early detection and treatment," she said. The reality: "You don't need to detect all cancers."

"We don't want this to be the answer," Moyer added. "We want to screen for the ones that are going to be aggressive, manage those early - and leave everyone else alone."

In an editorial published with the guideline in Annals of Internal Medicine, some urologists argue the panel underestimated PSA's value and overestimated its harms.

"What PSA screening offers the men is a substantial opportunity to avoid dying a particularly unpleasant death from prostate cancer," said editorial co-author Dr. William Catalona of Northwestern University, who pioneered the testing.

He spoke Monday from a meeting of the American Urological Association, where doctors debated the guideline's impact. The urology association advises that men be informed of the potential risks and benefits before screening.

But Dr. Otis Brawley, the American Cancer Society's chief medical officer, welcomed the task force's recommendation. He hoped it would help deter mass screenings, where men are given free PSAs at shopping malls and sports arenas without being told of the controversy, screenings that Brawley calls big business when health centers profit from the follow-up care.

"The question is, are we actually curing anybody who needs to be cured right now?" Brawley asked.

Too much PSA, or prostate-specific antigen, in the blood only sometimes signals prostate cancer is brewing. It also can mean a benign enlarged prostate or an infection. Only a biopsy can tell. Most men will get prostate cancer if they live long enough. Some 240,000 U.S. men a year are diagnosed with it, most with slow-growing tumors that carry a very low risk of morphing into the kind that can kill.

To evaluate whether routine screening saves lives, the task force analyzed previous research, focusing in particular on two huge studies in the U.S. and Europe. The panel's conclusion:

-Without screening, about 5 in every 1,000 men die of prostate cancer over 10 years. The European study found PSA testing might prevent one of those deaths, while the U.S. study found no difference.

-Of every 1,000 men screened, two will have a heart attack or stroke from resulting cancer treatment, and 30 to 40 will experience treatment-caused impotence or incontinence.

-Of every 3,000 men screened, one will die from complications of surgery.

Both the U.S. and European studies have flaws, and task force critics argue over which are most believable. And while U.S. death rates from prostate cancer have dropped over 20 years, the cancer society's Brawley says the drop began before PSA testing became widespread. Moreover, the risk of death is the same in Europe and the U.S. even though many more American men are screened, diagnosed and treated, he said.

"We need to do a better job of using PSA wisely," said Dr. Scott Eggener, a University of Chicago prostate cancer specialist who was disappointed the task force went so far. "Most people would agree that a well-informed, young, healthy patient should have the opportunity to talk about it with their physician."

But he's studying a way beyond the screen-or-not controversy: Having men with small, low-risk tumors postpone treatment in favor of "active surveillance," keeping close watch on their tumors and treating only if they grow. More than 100,000 men a year are candidates, concluded a recent meeting at the National Institutes of Health.

That approach could "maximize the benefits of screening," Eggener said.

In that time, there have been moments when she wondered if it would happen at all.

In April, 2010, she and her fiancé Ryan Ismirle got engaged. Six months later, they were devastated when she found a lump. It was a rare, aggressive form of breast cancer. Adams was just 29-years old.

Their wedding was put on hold.

“In a lot of ways it's been a lot more difficult for him,” Adams says. “It's I think easier to be sick and harder to stand beside somebody and watch them spin out of control.”

After a double mastectomy, chemotherapy and a series of reconstructive breast surgeries, Adams is still recovering - but she's feeling happy and healthy.

The wedding is back on, set for Saturday, June 2nd at Union Station. But it was only after finalizing those plans, they realized a few weeks ago that's the same date as the Komen Race for the Cure.

“To me, I feel like I have to do it. there's no other option,” Adams says. “It's just fate I guess it's the same day as my wedding.”

Adams feels most compelled to run because she was physically unable to do so last year with her friend and fellow chemo patient Barb. In January, Barb passed away from breast cancer.

“So this year it's really important for me to go back and run something that I should have been with her last year,” Adams says.

The race will be emotional, exhausting and time-wise, difficult to pull off. But her bridesmaids will help by running with her.

"I think this will kind of ground her and help her just focus on her for a few minutes in the crazy day,” Jennifer Giovannetti says.

All that pink, all those women. They're treating it like a last minute bachelorette party.

Now, as Ryan and Candice make the final lap toward their wedding day, they view her breast cancer as both a burden and a blessing.

“I think we've grown more as a couple in the past year and a half than most couples do in a decade,” Ismirle says.

And when they finally exchange those vows - "in sickness and in health" - they'll feel strength from the past and have faith in their future.

2013 will be a big year for Candice and Ryan. In January, doctors say, it will be safe for them to start a family. And next May, Adams will officially be considered in remission.

“You don't normally start out a marriage with such a serious sickness so for us it kind of makes me feel like there's not a single challenge we couldn't get through or handle,” Adams says.

And an even larger proportion of obese adolescents have such a risk, according to the alarming new numbers.

"What this is saying, unfortunately, is that we're losing the battle early with many kids," said Dr. Stephen Daniels, a University of Colorado School of Medicine expert who was not involved in the study.

People can keep their risk of heart disease very low if they reach age 45 or 50 at normal weight and with normal blood pressure, normal cholesterol and no diabetes. So these results are not good, he said.

The study was released Monday in the journal Pediatrics.

The Centers for Disease Control and Prevention research focused on 3,383 adolescents ages 12 through 19. The youths were part of an intensive national study that involves interviewing, weighing, measuring and performing medical tests on people across the country.

The ongoing CDC study is considered a gold standard for looking at national health trends, said Dr. William Mahle, an Emory University pediatric cardiologist.

So there was some good news, Mahle said, that the study found no increase in levels of obesity, high blood pressure or bad cholesterol during the years it covered — 1999 through 2008.

"All of us are looking for some sign or signal that we're making headway," said Mahle, who was not involved with the study. "So that was reassuring."

But one measure did get worse: The percentage of adolescents who were diagnosed with diabetes or pre-diabetes rose dramatically, from 9 percent to 21 percent. Pre-diabetics have higher than normal blood sugar levels, but not high enough to count as diabetes.

It's not clear why the proportion of kids with high blood sugar would increase while the measures for the other heart disease risk factors held steady. It may have something to do with the kind of test used to measure blood sugar, Daniels said.

Adolescents in the study were given a blood test that can give varying results depending on the day or time of day the test is given. Other tests, though more involved and more expensive, are considered more precise.

Daniels said it's possible another testing method might not have produced a swing so large.

That is possible, said Ashleigh May, the CDC epidemiologist who was the study's lead author.

"This study is just a first step to identify problems in youth. More work needs to be done to identify why this is happening and the advantages of using various test methods in this population," she said.

Overall the study found that 50 percent of overweight youths and 60 percent of obese youths had at least one risk factor for future heart disease.

But normal-weight kids aren't off the hook — 37 percent had at least one risk factor and could face increased chances for heart trouble as adults, the study suggests.

He's doing it with the goal of raising $50,000 to help find a cure for Alzheimer's disease.

The 24-year-old man had never rowed before. But now he's rowing 10-12 hours per day and sleeping most nights on his boat.

WATCH: ABC7's Ben Eisler has the story.

A study put on by the Salk Institute in Southern California concluded that there could be a link between the hours during the day a person eats and whether they're obese, according to U.S. News and World Report.

The original study, as published in the journal Cell Metabolism, involved two groups of mice eating the same thing; one was fed during a strict 8-hour window and the other ate throughout the day.

At the end of the study's time period, the group that ate the high-fat diet without time restrictions saw a marked increase in weight and blood sugar. U.S. News also reports that the other group of mice, which ate within the time window, maintained its weight.

Satchidananda Panda, a Salk Institute researcher and an author of the study, told New Scientist that one of the contributing, correlating factors in humans may be that people tend to eat less healthy food near the end of the day and during late-night hours.

That idea is backed up by Kathleen Doheny and Dr. Brulinda Nazario, who write on WebMD that a study in the journal Obesity says that eating at abnormal times can accelerate weight gain.

"I noticed that the jowls and neck line were sagging. I thought to myself, 'Oh my gosh — do I look like this?'" Miller said.

Miller said she doesn't like her jaw line or her neck. She thinks they make her look a lot older when, she says, she feels young inside.

Miller decided to get a new type of facelift dubbed the "FaceTime facelift" by Dr. Robert Sigal, who invented the idea because of his wife.

"[She] didn't like the way she looked when she got an iPad and FaceTime with our daughters," Dr. Sigal said.

A traditional facelift would leave a scar under a person's chin that would show up while video chatting. Instead, Dr. Sigal makes an incision behind the ears.

"The goal is to lift the tissues from behind," he said. "Then we use sling and modifications to bring muscle back and change direction."

Miller had the procedure two weeks ago, and though she's still a bit bruised, she's already thrilled with the results, a 50th birthday present for herself.

"I love it, I love it," she said. "I have such great definition now and the jowls are gone and everyone I know says I look so much younger."

A "facetime facelift" procedure costs about $10,000.

But, a new study says that doesn't make where you go out to eat healthy.

The study, conducted by the Rand corporation, found 96 percent of main entrees sold at top U.S. chain eateries exceed daily limits for calories, sodium, fat and saturated fat recommended by the U.S. Department of Agriculture.

Some other interesting finds: appetizers contain more calories than one entrée. Family restaurants are sometimes worse than fast food, filled with more calories, fat and sodium.

And kid specialty drinks aren't healthy. There's more fat and saturated fat on average than regular drinks.

This study comes in the midst of the restaurant industry offering healthier options including children's meals. Even then, the study says, the healthy dining seal of approval is too generous on sodium.

She returned to her doctor and had a biopsy. A week later, she learned she had breast cancer.

Like many patients, she acted quickly and proactively. She had a double mastectomy. But afterward, she didn't want implants.

“I would much rather have my own tissue than to have the implants,” Brion says.

So she chose to have a new type of breast reconstruction, using her love handle tissue. It was a decision her husband supported.

“I do think probably the best thing in so far as it’s her own tissue - there's not a foreign matter in there,” says he husband Tony Brion.

Previously, surgeons have taken tissue from abdominal or buttocks area.

Plastic surgeon Dr. Ariel Rad says the procedure can slim the waistline and provides enough tissue to rebuild an entire breast.

And Dr. Rad is able to connect a blood vessel in the tissue to a blood vessel in the chest for blood. circulation.

“I'm actually disconnecting that tissue entirely and then hooking up the blood vessels back up to blood vessels in the breast area to restore the blood flow through the tissue so that it can live,” Rad says.

Six weeks after her surgery, Brion says she's very happy with the results.

“It's very natural feeling. They look normal like a real breast,” she says. “I lost 10 pounds! I've actually gone down a size in my clothes and feel much better about myself.”

After 18 months of worrying, she's now cancer-free and looking forward to life with her family.

“To be able to just go on and do what we want to do and not be concerned anymore - with no more surgeries down the road - this was perfect,” she says.

Zithromax, or azithromycin, is more expensive than other antibiotics, but it's popular because it often can be taken for fewer days. But the results suggest doctors should prescribe other options for people already prone to heart problems, the researchers and other experts said.

Vanderbilt University researchers analyzed health records and data on millions of prescriptions for several antibiotics given to about 540,000 Tennessee Medicaid patients from 1992 to 2006. There were 29 heart-related deaths among those who took Zithromax during five days of treatment. Their risk of death while taking the drug was more than double that of patients on another antibiotic, amoxicillin, or those who took none.

To compare risks, the researchers calculated that the number of deaths per 1 million courses of antibiotics would be about 85 among Zithromax patients versus 32 among amoxicillin patients and 30 among those on no antibiotics. The highest risks were in Zithromax patients with existing heart problems.

Patients in each group started out with comparable risks for heart trouble, the researchers said.

The results suggest there would be 47 extra heart-related deaths per 1 million courses of treatment with Zithromax, compared with amoxicillin. A usual treatment course for Zithromax is about five days, versus about 10 days for amoxicillin and other antibiotics. Zithromax is at least twice as expensive as generic amoxicillin; online prescription drug sellers charge a few dollars per pill for Zithromax.

"People need to recognize that the overall risk is low," said Dr. Harlan Krumholz, a Yale University health outcomes specialist who was not involved in the study. More research is needed to confirm the findings, but still, he said patients with heart disease "should probably be steered away" from Zithromax for now.

The study appears in Thursday's New England Journal of Medicine. The National Heart, Lung and Blood Institute helped pay for the research.

Zithromax, marketed by Pfizer Inc., has been available in the United States for two decades. It's often used to treat bronchitis, sinus infections and pneumonia. Wayne Ray, a Vanderbilt professor of medicine, decided to study the drug's risks because of evidence linking it with potential heart rhythm problems. Also, antibiotics in the same class as Zithromax have been linked with sudden cardiac death.

Zithromax is among top-selling antibiotics. U.S. sales last year totaled $464 million, according to IMS Health, a health care information and services company.

Pfizer issued a statement saying it would thoroughly review the study. "Patient safety is of the utmost importance to Pfizer and we continuously monitor the safety and efficacy of our products to ensure that the benefits and risks are accurately described," the company said.

Patients studied were age 50 on average and not hospitalized. Most had common ailments, including sinus infections and bronchitis. Those on Zithromax were about as healthy as those on other antibiotics, making it unlikely that an underlying condition might explain the increased death risk.

Medicaid patients generally have more disability and lower incomes than other patients, so whether the same results would be found in the general population is uncertain, Ray said.

Dr. Bruce Psaty, a professor of medicine at the University of Washington, said doctors and patients need to know about the potential risks. He said the results also raise concerns about long-term use of Zithromax, which other research suggests could benefit people with severe lung disease. Additional research is needed to determine if that kind of use could be dangerous, he said.

However, the trend, which came to America through a salon in Alexandria several years ago, might be tainted. A new British study says that carp, the fish used in the treatment, may carry bacteria responsible for a variety of dangerous skin and soft tissue infections.

More than 6,000 people got the fish pedicures in the first five months it was offered in 2008, but now health officials are warning that anyone with open sores or skin cuts, diabetes, cancer and older people should avoid the treatment.

Because of this, more than 10 states have banned the practice. The Centers for Disease control says that it's nearly impossible to disinfect or sanitize live fish, among other reasons. No illnesses have been reported in the United States, though, the CDC says.

As of now, there have only been a handful of infections reported in Great Britain. However, last spring, fish inspectors found several strains of bacteria inside fish destined for spas.

The 10 week old pups will soon pack a power exceeding man and machine, alerting a diabetic 20 minutes before even a glucose monitoring system can.

One pup, Sugar, an 8-month old Warren retriever, is trained to signal when her owner -- Arlingtonian Michele Hunter -- is having a blood sugar high or low.

“She might be alerting right now so I should check if that's all right,” Hunter says.

Sugar's sense of smell is so intense that she catches Michele's dropping glucose levels just three points outside her range, staving off seizures, blackouts and ER emergencies.

Dan is the man behind the dogs. He was diagnosed with diabetes at 30, when he was perfectly fit Marine training K-9's for explosives and narcotics detection.

Warren's top trainer, Cheri Campbell, starts intensive obedience training at seven weeks. They advance to sniffing actual blood samples -- high sugar in the blood gives off a cotton candy scent. Low sugar an acetone one, like nail polish remover.

It takes hundreds of hours of work. By just 3-4 months old, they're ready for service.

The cost to breed train and deliver these pups is $40,000, with help foundation families pay half that.

Expensive, yes. But how to put a price on a puppy who delivers peace of mind.

All have been wounded in combat, more than half are now amputees. Wednesday, they are all being awarded Segways. The idea is to not only to improve their mobility and independence, but also lives that have been beaten and battered.

The number of service members who lost limbs in combat reached an all-time high last year in Afghanistan. These recipients come from 26 different states, including locals from Maryland and Virginia. In some cases they have lost both legs.

A clear sign of the times, modern technology assisting veterans after giving so much in a setting that has been around since about the start of time - warfare.

Most here were injured in IED explosions in Iraq and Afghanistan and spent significant time at Walter Reed. The Arlington County police department has volunteered to train the service members to master their new tactical equipment.

It is currently illegal to sell your organs. The National Organ Transplant Act, a federal law, states that it’s against the law to sell human organs and tissue.

Bioethicists fear that if people can sell their organs, the poor could be exploited.

Read the full NPR story here.

But her gloves sparked online speculation that she might be using them to hide wrinkly, old-looking hands.

For years, Madonna and 47-year-old Sarah Jessica Parker have been criticized for having veiny, bony hands that make them look older.

D.C. artist Evie Jones said that's exactly what she doesn't like about her own hands.

"My hands, since I was 25, have looked like 60," Jones said. "I've had friends look at me and go, 'Oh my god, what's wrong with your hands?'"

Jones' hands bother her so much, she's getting a "hand lift" — a procedure many plastic surgeons currently offer.

"It's definitely increasing in frequency," said Dr. Marwan Khalifeh, a plastic surgeon in Chevy Chase, Md.

Dr. Khalifeh said as people age, the skin on their hands gets thinner, which exposes their tendons and veins.

To rejuvenate old-looking hands, a filler, like Radiesse, is injected.

"That basically lifts up the skin and masks the areas between the tendons and areas between the veins," Dr. Khalifeh said.

A laser or chemical peel helps erase brown age spots on the skin.

The 20-minute procedure may cause bruising for a few days, but results can be dramatic.

Jones had her first hand lift a few years ago and loved the improvement. Because results only last about a year, she came back for round two. 

"They're nice hands. They look good; I'm not bothered by them anymore," she said.

The procedure costs about $1,500. Doctors say the best way to keep your hands looking young is to wear sunscreen on them every day.

In a proclamation by the president for National Women’s Health Week, the administration said that women’s health needs to be prioritized.

“Women have guided our country toward prosperity and progress, and our Nation's success depends on their well-being. While women often play a leading role in making medical decisions for their families, their own health care needs have too often gone unmet,” the president said in a proclamation.

The health week is aimed at “advancing gender equality” within health care as part of the president’s Affordable Care Act, which was a part of his larger health care overhaul.

In the new legislation, “we are reversing many of the worst abuses of the health insurance industry. Beginning in 2014, many insurers will no longer be allowed to charge women higher premiums simply because of their gender, and it will be illegal for most insurance companies to deny coverage to women because they have a pre-existing condition, including cancer or pregnancy,” the statement read.

The plans will also require that health plans will cover maternity care as well as ensure women gain coverage for their children.

The leading cause of death for women of all ages and races in the U.S., according to CDC statistics, is heart disease, by 25.1 percent, and cancer by 22.1 percent.

She has a rare condition, called necrotizing fasciitis, in which marauding bacteria run rampant through tissue. Affected areas sometimes have to be surgically removed to save the patient's life.

HOW OFTEN DO PEOPLE GET THESE INFECTIONS?

The government estimates roughly 750 flesh-eating bacteria cases occur each year, usually caused by a type of strep germ.

However, Aimee Copeland's infection was caused by another type of bacteria, Aeromonas hydrophila. Those cases are even rarer. One expert knew of only a few reported over the past few decades.

DO MOST PEOPLE SURVIVE?

Yes, but about 1 in 5 people with the most common kind of flesh-eating strep bacteria die. There are few statistics on Aeromonas-caused cases like Copeland's.

HOW DOES SOMETHING LIKE THIS HAPPEN?

The germs that can cause flesh-eating disease are common in warm and brackish waters like ponds, lakes and streams. They are not a threat to most people. An infectious disease expert at Vanderbilt University, Dr. William Schaffner, said: "I could dive in that same stream, in the same place, and if I don't injure myself I'm going to be perfectly fine. It's not going to get on the surface of my skin and burrow in. It doesn't do that."

But a cut or gash — especially a deep one — opens the door for flesh-eating bacteria.

IS THERE ANYTHING YOU CAN DO TO AVOID SUCH AN INFECTION?

Prompt and thorough medical care should stop the infection before it spreads. A wound can look clean, but if it's sutured or stapled up too soon it can create the kind of oxygen-deprived environment that helps these bacteria multiply and spread internally. Once established, these rare infections can be tricky to diagnose and treat.

Also, Aeromonas is resistant to some common antibiotics that work against strep and other infections, so it's important that doctors use the best medicines.

ARE SOME PEOPLE MORE AT RISK?

Yes, people with weakened immune systems are. Copeland's family has not said whether she had some type of medical condition that could have made her more vulnerable and relatives could not be reached for comment Monday. Her doctors, meanwhile, have refused interviews.